Provention Bio, Inc.
PRVBDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695357
Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Provention Bio, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 112 | 1 | 113 | +2 |
| Shares | 23.7M | 200 | 24.2M | +499.6K (+2.1%) |
| Value | $133.0M | $1.00K | $177.0M | +$43.9M (+33.0%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Provention Bio, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| VR Adviser, LLC | 1,118,653 | $8.19M | 1.33% |
| Adage Capital Partners GP, L.L.C. | 709,323 | $5.19M | 0.01% |
| D. E. Shaw & Co., Inc. | 50,782 | $372.0K | 0.00% |
| Nisa Investment Advisors, LLC | 45,400 | $332.0K | 0.00% |
| Atom Investors LP | 42,680 | $312.0K | 0.15% |
| HAP Trading, LLC | 37,539 | $275.0K | 0.03% |
| HighTower Advisors, LLC | 23,665 | $174.0K | 0.00% |
| Price T Rowe Associates Inc | 19,876 | $145.0K | 0.00% |
| Private Advisor Group, LLC | 17,707 | $129.0K | 0.00% |
| Franklin Resources Inc | 16,926 | $124.0K | 0.00% |
| Two Sigma Investments, LP | 16,600 | $122.0K | 0.00% |
| Engineers Gate Manager LP | 16,500 | $121.0K | 0.00% |
| Sawtooth Solutions, LLC | 10,221 | $75.0K | 0.01% |
| BIT Capital GmbH | 7,500 | $54.9K | 0.01% |
| Amalgamated Bank | 6,706 | $49.0K | 0.00% |
| Amalgamated Financial Corp. | 6,706 | $49.0K | 0.00% |
| High Net Worth Advisory Group LLC | 2,500 | $18.0K | 0.01% |
| FMR LLC | 833 | $6.00K | 0.00% |
| Money Concepts Capital Corp | 571 | $4.00K | 0.00% |
| Proequities, Inc. | 400 | $3.00K | 0.00% |
| Aquatic Capital Management LLC | 100 | $1.00K | 0.00% |
Sold out (19)
Institutions that held Provention Bio, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Millennium Management LLC | 546,202 | $3.07M |
| Truist Financial Corp | 150,000 | $843.0K |
| Group One Trading, L.P. | 65,482 | $368.0K |
| Panagora Asset Management Inc | 45,986 | $258.0K |
| Trexquant Investment LP | 40,552 | $228.0K |
| Aristides Capital LLC | 35,256 | $198.0K |
| Parallax Volatility Advisers, L.P. | 30,177 | $170.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 27,864 | $157.0K |
| Dynamic Technology Lab Private Ltd | 27,844 | $156.0K |
| Prudential Financial Inc | 25,300 | $142.0K |
| Caxton Associates LP | 21,198 | $119.0K |
| Algert Global LLC | 18,150 | $102.0K |
| Alpine Global Management, LLC | 16,074 | $90.0K |
| SG Americas Securities, LLC | 13,990 | $79.0K |
| Wolverine Trading, LLC | 10,661 | $61.0K |
| Parallel Advisors, LLC | 1,161 | $7.00K |
| Bedel Financial Consulting, Inc. | 251 | $1.00K |
| CWM, LLC | 62 | $0 |
| Edge Wealth Management LLC | 50 | – |
Not filed for Q1 2022 yet (1)
Institutions that held Provention Bio, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Reilly Financial Advisors, LLC | 200 | $1.00K |